Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes
- PMID: 31314968
- DOI: 10.1056/NEJMoa1803180
Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes
Abstract
Background: The relationship between outpatient systolic and diastolic blood pressure and cardiovascular outcomes remains unclear and has been complicated by recently revised guidelines with two different thresholds (≥140/90 mm Hg and ≥130/80 mm Hg) for treating hypertension.
Methods: Using data from 1.3 million adults in a general outpatient population, we performed a multivariable Cox survival analysis to determine the effect of the burden of systolic and diastolic hypertension on a composite outcome of myocardial infarction, ischemic stroke, or hemorrhagic stroke over a period of 8 years. The analysis controlled for demographic characteristics and coexisting conditions.
Results: The burdens of systolic and diastolic hypertension each independently predicted adverse outcomes. In survival models, a continuous burden of systolic hypertension (≥140 mm Hg; hazard ratio per unit increase in z score, 1.18; 95% confidence interval [CI], 1.17 to 1.18) and diastolic hypertension (≥90 mm Hg; hazard ratio per unit increase in z score, 1.06; 95% CI, 1.06 to 1.07) independently predicted the composite outcome. Similar results were observed with the lower threshold of hypertension (≥130/80 mm Hg) and with systolic and diastolic blood pressures used as predictors without hypertension thresholds. A J-curve relation between diastolic blood pressure and outcomes was seen that was explained at least in part by age and other covariates and by a higher effect of systolic hypertension among persons in the lowest quartile of diastolic blood pressure.
Conclusions: Although systolic blood-pressure elevation had a greater effect on outcomes, both systolic and diastolic hypertension independently influenced the risk of adverse cardiovascular events, regardless of the definition of hypertension (≥140/90 mm Hg or ≥130/80 mm Hg). (Funded by the Kaiser Permanente Northern California Community Benefit Program.).
Copyright © 2019 Massachusetts Medical Society.
Comment in
-
Systolic and diastolic hypertension independently predict CVD risk.Nat Rev Cardiol. 2019 Oct;16(10):578-579. doi: 10.1038/s41569-019-0248-4. Nat Rev Cardiol. 2019. PMID: 31366923 No abstract available.
-
Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.N Engl J Med. 2019 Oct 24;381(17):1690. doi: 10.1056/NEJMc1911059. N Engl J Med. 2019. PMID: 31644858 No abstract available.
-
Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.N Engl J Med. 2019 Oct 24;381(17):1690-1691. doi: 10.1056/NEJMc1911059. N Engl J Med. 2019. PMID: 31644859 No abstract available.
-
Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.N Engl J Med. 2019 Oct 24;381(17):1691-1692. doi: 10.1056/NEJMc1911059. N Engl J Med. 2019. PMID: 31644860 No abstract available.
Similar articles
-
Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.JAMA Netw Open. 2021 Feb 1;4(2):e2037554. doi: 10.1001/jamanetworkopen.2020.37554. JAMA Netw Open. 2021. PMID: 33595663 Free PMC article.
-
Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).Hypertension. 2018 May;71(5):840-847. doi: 10.1161/HYPERTENSIONAHA.117.10177. Epub 2018 Mar 26. Hypertension. 2018. PMID: 29581214 Clinical Trial.
-
Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.Am J Med. 2018 Oct;131(10):1228-1233.e1. doi: 10.1016/j.amjmed.2018.05.022. Epub 2018 Jun 12. Am J Med. 2018. PMID: 29906425 Clinical Trial.
-
[Hypertension in the elderly].Bull Acad Natl Med. 2006 Apr-May;190(4-5):793-805; discussion 806, 873-6. Bull Acad Natl Med. 2006. PMID: 17195607 Review. French.
-
Prognosis of diastolic and systolic orthostatic hypotension in older persons.Arch Intern Med. 1999 Feb 8;159(3):273-80. doi: 10.1001/archinte.159.3.273. Arch Intern Med. 1999. PMID: 9989539 Review.
Cited by
-
Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials.Hypertens Res. 2024 Nov 14. doi: 10.1038/s41440-024-01949-4. Online ahead of print. Hypertens Res. 2024. PMID: 39543413 Review.
-
Re-evaluating cardiovascular risk in systolic-dominant, diastolic-dominant and parallelly-elevated hypertension: insights from northeast rural cardiovascular health study.Sci Rep. 2024 Nov 10;14(1):27443. doi: 10.1038/s41598-024-79189-2. Sci Rep. 2024. PMID: 39523441 Free PMC article.
-
Machine learning-based classification of valvular heart disease using cardiovascular risk factors.Sci Rep. 2024 Oct 17;14(1):24396. doi: 10.1038/s41598-024-67973-z. Sci Rep. 2024. PMID: 39420025 Free PMC article.
-
Blood Pressure and Cardiovascular Risk in Women With Breast Cancer: The Pathways Heart Study.JACC Adv. 2024 Aug 14;3(9):101207. doi: 10.1016/j.jacadv.2024.101207. eCollection 2024 Sep. JACC Adv. 2024. PMID: 39238853 Free PMC article.
-
Matrix sketching framework for linear mixed models in association studies.Genome Res. 2024 Oct 11;34(9):1304-1311. doi: 10.1101/gr.279230.124. Genome Res. 2024. PMID: 39231610 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical